Spinnengifte punkten mit Komplexität laborpraxis.vogel.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from laborpraxis.vogel.de Daily Mail and Mail on Sunday newspapers.
Galderma Receives FDA Approval for Restylane® Defyne for Chin Augmentation
Represents second approved indication for Restylane Defyne in U.S.; expands Galderma Aesthetics growing Restylane product portfolio
News provided by
Share this article
Share this article
FORT WORTH, Texas, Feb. 2, 2021 /PRNewswire/ Galderma announces that the U.S. Food and Drug Administration (FDA) has approved
Restylane
® Defyne for the augmentation and correction of mild to moderate chin retrusion for adults over the age of 21.
1 In 2020 alone, online searches for chin enhancement increased by 185 percent, reinforcing the emerging patient need for a product like
Restylane Defyne.
2
Restylane Defyne is the first and only chin filler to demonstrate results across a wide range of participants